Clin2
NCT07765615Possibly a fitNot yet recruiting

Personalized antibiotic dosing after kidney transplant

Transplant Recipient (Kidney)

Part of Infections, Kidney & urinary clinical trials.

This study looks at giving anti-infection medications (antibiotics) in a more personalized way soon after a kidney transplant. By carefully adjusting the dose, doctors hope to prevent infections while keeping the new kidney safe.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You are within the first 5 days after your first kidney transplant.
  • You will be receiving anti-infection medication (antibiotics) for at least 5 days after surgery.
  • You will have a urinary catheter in place for at least 48 hours after surgery, so we can collect urine samples.
  • You are expected to have good early kidney function and not need dialysis right after the transplant.
  • You are not pregnant or breastfeeding, and you do not have severe liver problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07815938Not yet recruiting
Personalizing tacrolimus dosing after kidney transplant

This study looks at how well tacrolimus, a medicine that prevents kidney rejection, works in people after a kidney transplant. By checking your immune system and your medicine levels, the goal is to find the best dose for each person to keep your new kidney healthy.

NCT07106125Not yet recruiting· Phase 4
Extended antibiotics after kidney transplant

This study looks at whether continuing an antibiotic called TMP-SMX (Bactrim) for longer helps prevent urinary tract infections after a kidney transplant. If you've already taken it safely for 6 months, you may qualify to continue it for another 6 months or stop, to see which is better.

San Francisco, California
NCT07407673Not yet recruiting· Phase 3
Preventing blood infections after kidney transplant

This study tests whether giving an antibiotic after a kidney transplant can prevent bloodstream infections. Participants who have bacteria in their urine in the first month after transplant may be eligible.

Aarhus
NCT05432765Not yet recruiting
Personalized medicine for kidney transplant recipients

This study tests a personalized approach to managing immunosuppression after a kidney transplant to improve long-term kidney function. It may help find the right dose of tacrolimus for each person.

Gainesville, Florida
NCT05597540Recruiting· Phase 3
Shorter antibiotics for kidney transplant kidney infections

This study compares giving antibiotics for 7 days versus 14 days to treat acute kidney infections (pyelonephritis) in people with kidney transplants. It aims to see if the shorter course works just as well and is safer or easier to complete.

Bordeaux
NCT06825117Enrolling by invitation
Probiotics after kidney transplant

This trial tests whether taking a probiotic supplement helps people recovering from a kidney transplant. If you are between 18 and 75 years old and had a smooth recovery in the first month after surgery, you may be able to join.

Udine

Hear when a new Transplant Recipient (Kidney) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.